Managing Director, Dr Richard Lipscombe presents “Emerging Mass Spectrometry Approaches To Cancer Biomarker Discovery and QA/QC for Characterising Biologics” at invitation only events in Taipei (27th June), Seoul (29th June) and Tokyo (30th June).